StockNews.AI
USNA
StockNews.AI
28 days

USANA Health Sciences Reports Second Quarter 2025 Results and Reiterates Full-Year Outlook

1. USANA reported an 11% increase in net sales year-over-year. 2. Net earnings declined slightly from $10.4 million to $9.7 million.

Earnings
+12.33%Current Return
VS
+0.86%S&P 500
$31.5407/22 04:11 PM EDTEvent Start
$35.4307/23 10:50 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

The significant sales growth suggests positive market positioning, despite a slight decrease in earnings.

How important is it?

Sales growth may attract investor interest, although earnings decline raises caution.

Why Short Term?

Investors may react quickly to the sales growth, impacting USNA's stock price in the short term.

Related Companies

Nutraceuticals CompaniesHerbalife Nutrition Ltd. (HLF)Amway
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended June 28, 2025. Key Financial Results Second Quarter 2025 vs. Second Quarter 2024 Net sales of $236 million versus $213 million, representing 11% year-over-year growth. Net earnings of $9.7 million versus $10.4 million. Diluted EPS of $0.52 as compared with $0.54. Adjusted diluted EPS(1) of $0.74 as compared with $0.54. Adjusted EBITDA(2) of $30 million.

Related News